Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.356
Filter
1.
J Magn Reson ; 357: 107585, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37952430

ABSTRACT

We propose a data-driven technique to infer microscopic physical quantities from nuclear magnetic resonance (NMR) spectra, in which the data size and quality required for the Bayesian inference are investigated. The 59Co-NMR measurement of YbCo2Zn20 single crystal generates complex spectra with 28 peaks. By exploiting the site symmetry in the crystal structure, the isotropic Knight shift Kiso and nuclear quadrupole resonance (NQR) frequency νQ were respectively estimated to be Kiso=0.7822±0.0090% and νQ=2.008±0.016 MHz (T=20 K and H≃10.2 T) by analyzing only 30 data points from one spectrum. The estimated νQ is consistent with the precise value obtained in the NQR experiment. Our method can significantly reduce the measurement time and the computational cost of data analysis in NMR experiments.

2.
J Phys Condens Matter ; 35(36)2023 Jun 12.
Article in English | MEDLINE | ID: mdl-37253380

ABSTRACT

We have successfully grown single crystals of a novel ytterbium-based layered compoundYb4RuGe8and studied its structural, magnetic, thermal, and transport properties. The magnetic susceptibility has a broad peak caused by the Kondo effect at approximately40 Kand is enhanced below15 Kowing to the development of additional magnetic correlations. An analysis with the grand-Kadowaki-Woods relation reveals that the low-temperature state except for the effect of the additional magnetic correlations is a heavy-mass Fermi liquid.

3.
Ultrasound Obstet Gynecol ; 61(5): 593-600, 2023 05.
Article in English | MEDLINE | ID: mdl-36273401

ABSTRACT

OBJECTIVE: To investigate the criteria, based on fetal TR waveforms in late gestation, to predict biventricular circulation (BV) after birth in cases of tricuspid valve dysplasia (TVD) or Ebstein's anomaly diagnosed during the fetal period. METHODS: We included 35 consecutive cases diagnosed with TVD or Ebstein's anomaly during the fetal period between January 2008 and December 2021 at Kanagawa Children's Medical Center, Kanagawa, Japan. The maximum velocity and change in pressure over time of tricuspid regurgitation (TR) jet (dP/dt), estimated using TR waveforms obtained during the late-gestation period (gestational age ≥ 28 weeks), were collected from patient records. dP/dt was calculated by dividing the change in estimated right ventricular pressure obtained using Bernoulli's principle by the time taken for the TR maximum velocity to change from one-third to two-thirds of its peak value. The outcome was divided into four categories: BV, single ventricular circulation, neonatal death and fetal death. Patients with BV were included in the BV group, while patients with single ventricular circulation, neonatal death or fetal death were included in the non-BV (NBV) group. RESULTS: Overall, 19 and 16 patients were included in the BV and NBV groups, respectively. The median TR maximum velocity was 3.3 (range, 2.4-3.6) m/s in the BV group and 1.9 (range, 1.0-3.3) m/s in the NBV group. There were no cases of postnatal BV in fetuses with TR maximum velocity < 2.4 m/s; cases with TR maximum velocity of 2.4-3.3 m/s were observed in both BV and NBV groups. Receiver-operating-characteristics-curve analysis was performed on the 11 patients in the BV group and five patients in the NBV group with a TR maximum velocity of 2.4-3.3 m/s. dP/dt ≥ 350 mmHg/s and TR maximum velocity ≥ 2.9 m/s were identified as criteria for predicting the outcome in such cases. The performance of dP/dt ≥ 350 mmHg/s in predicting BV after birth in fetuses with TVD or Ebstein's anomaly was higher compared to that of TR maximum velocity ≥ 2.9 m/s (sensitivity, 90.9% vs 72.3% and specificity, 80.0% vs 80.0%, respectively). CONCLUSIONS: In fetuses with TVD or Ebstein's anomaly, the postnatal outcome may be BV or NBV when the TR maximum velocity is 2.4-3.3 m/s. In such cases, by combining the TR maximum velocity with dP/dt ≥ 350 mmHg/s, BV after birth may be predicted with greater accuracy. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.


Subject(s)
Ebstein Anomaly , Perinatal Death , Tricuspid Valve Insufficiency , Child , Infant, Newborn , Female , Humans , Pregnancy , Infant , Ebstein Anomaly/diagnostic imaging , Tricuspid Valve Insufficiency/diagnostic imaging , Tricuspid Valve/diagnostic imaging , Fetal Death , Fetus , Parturition , Retrospective Studies
4.
Ann Oncol ; 33(2): 216-226, 2022 02.
Article in English | MEDLINE | ID: mdl-34843940

ABSTRACT

BACKGROUND: Cancer of unknown primary (CUP) has a poor prognosis. Given the recent approval of immune checkpoint inhibitors for several cancer types, we carried out a multicenter phase II study to assess the efficacy of nivolumab for patients with CUP. PATIENTS AND METHODS: Patients with CUP who were previously treated with at least one line of systemic chemotherapy constituted the principal study population. Previously untreated patients with CUP were also enrolled for exploratory analysis. Nivolumab (240 mg/body) was administered every 2 weeks for up to 52 cycles. The primary endpoint was objective response rate in previously treated patients as determined by blinded independent central review according to RECIST version 1.1. RESULTS: Fifty-six patients with CUP were enrolled in the trial. For the 45 previously treated patients, objective response rate was 22.2% [95% confidence interval (CI), 11.2% to 37.1%], with a median progression-free survival and overall survival of 4.0 months (95% CI, 1.9-5.8 months) and 15.9 months (95% CI, 8.4-21.5 months), respectively. Similar clinical benefits were also observed in the 11 previously untreated patients. Better clinical efficacy of nivolumab was apparent for tumors with a higher programmed death-ligand 1 expression level, for those with a higher tumor mutation burden, and for microsatellite instability-high tumors. In contrast, no differences in efficacy were apparent between tumor subgroups based on estimated tissue of origin. Adverse events were consistent with the known safety profile of nivolumab. No treatment-related death was observed. CONCLUSIONS: Our results demonstrate a clinical benefit of nivolumab for patients with CUP, suggesting that nivolumab is a potential additional therapeutic option for CUP.


Subject(s)
Neoplasms, Unknown Primary , Nivolumab , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Humans , Microsatellite Instability , Neoplasms, Unknown Primary/drug therapy , Nivolumab/adverse effects , Progression-Free Survival , Response Evaluation Criteria in Solid Tumors
5.
Prog Biophys Mol Biol ; 168: 1-2, 2022 01.
Article in English | MEDLINE | ID: mdl-34952029
6.
Physiol Res ; 69(6): 1029-1038, 2020 12 22.
Article in English | MEDLINE | ID: mdl-33251809

ABSTRACT

Antifreeze proteins are an effective additive for low-temperature preservation of solid organs. Here, we compared static hypothermic preservation with and without antifreeze glycoprotein (AFGP), followed by nonfreezing cryopreservation of rat hearts. The heart was surgically extracted and immersed in one of the cardioplegia solutions after cardiac arrest. Control rat hearts (n=6) were immersed in University of Wisconsin (UW) solution whereas AFGP-treated hearts (AFGP group) (n=6) were immersed in UW solution containing 500 ?g/ml AFGP. After static hypothermic preservation, a Langendorff apparatus was used to reperfuse the coronary arteries with oxygenated Krebs-Henseleit solution. After 30, 60, 90, and 120 min, the heart rate (HR), coronary flow (CF), cardiac contractile force (max dP/dt), and cardiac diastolic force (min dP/dt) were measured. Tissue water content (TWC) and tissue adenosine triphosphate (ATP) levels in the reperfused preserved hearts were also assessed. All the parameters were compared between the control and AFGP groups. Compared with the control group, the AFGP group had significantly (p<0.05) higher values of the following parameters: HR at 60, 90, and 120 min; CF at all four time points; max dP/dt at 90 min; min dP/dt at 90 and 120 min; and tissue ATP levels at 120 min. TWC did not differ significantly between the groups. The higher HR, CF, max dP/dt, min dP/dt, and tissue ATP levels in the AFGP compared with those in control hearts suggested that AFGP conferred superior hemodynamic and metabolic functions. Thus, AFGP might be a useful additive for the static/nonfreezing hypothermic preservation of hearts.


Subject(s)
Antifreeze Proteins/pharmacology , Cardioplegic Solutions/pharmacology , Cryopreservation/methods , Heart , Adenosine Triphosphate/metabolism , Animals , Male , Models, Animal , Rats , Rats, Wistar , Transplants/supply & distribution
7.
Phys Rev Lett ; 123(2): 027205, 2019 Jul 12.
Article in English | MEDLINE | ID: mdl-31386536

ABSTRACT

We report on negative thermal expansion (NTE) in the high-field, half-magnetization plateau phase of the frustrated magnetic insulator CdCr_{2}O_{4}. Using dilatometry, we precisely map the phase diagram at fields of up to 30 T and identify a strong NTE associated with the collinear half-magnetization plateau for B>27 T. The resulting phase diagram is compared with a microscopic theory for spin-lattice coupling, and the origin of the NTE is identified as a large negative change in magnetization with temperature, coming from a nearly localized band of spin excitations in the plateau phase. These results provide useful guidelines for the discovery of new NTE materials.

8.
Ultrasound Obstet Gynecol ; 54(2): 199-206, 2019 Aug.
Article in English | MEDLINE | ID: mdl-30381845

ABSTRACT

OBJECTIVE: To evaluate Sylvian fissure development by assessing Sylvian fissure angles in fetuses with malformation of cortical development (MCD). METHODS: This was a retrospective study of 22 fetuses with MCD. Cases with a stored three-dimensional (3D) brain volume acquired at 18 + 0 to 30 + 6 weeks of gestation at an ultrasound-based research clinic between January 2010 and December 2017 were identified through a database. Of the 22 fetuses, seven had an extracranial abnormality, such as cardiac, renal, gastrointestinal and/or digital anomalies, and five had a minor abnormality such as micrognathia, low-set ears and/or single umbilical artery. To confirm the final clinical diagnosis of brain abnormality, postmortem histological findings or prenatal or postnatal magnetic resonance images were used. For measurement of Sylvian fissure angle, an anterior coronal plane of the fetal brain on transvaginal 3D volume multiplanar imaging was visualized as a single image from the three orthogonal views. The right and left Sylvian fissure angles were measured between a horizontal reference line (0°) and a line drawn along the upper side of the respective Sylvian fissure. The Sylvian fissure angle on both sides was plotted on the graphs of the reference ranges for gestational age in weeks. RESULTS: In 21 (95.5%; 95% CI, 86.8-100.0%) of 22 fetuses with MCD, the Sylvian fissure angle on one or both sides was larger than the 90th percentile of the normal reference. There was one case with apparent focal MCD in the parietal lobe, but the Sylvian fissure angles were normal. A case with apparent unilateral cortical dysplasia and one with apparent unilateral schizencephaly had conspicuous discrepancies between the left and right Sylvian fissure angles. Abnormal genetic test results were obtained in six cases, including four cases with a mutation in a single gene. CONCLUSIONS: This study has shown that the Sylvian fissures, as defined by the Sylvian fissure angle, have delayed development in most MCD cases prior to the diagnosis of the condition. The Sylvian fissure angle may potentially be a strong indicator for the subsequent development of cortical malformation, before the time point at which the gyri and sulci become obvious on the fetal brain surface. Further research is required to validate these findings. © 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.


Subject(s)
Cerebral Cortex/abnormalities , Cerebral Cortex/diagnostic imaging , Congenital Abnormalities/diagnostic imaging , Malformations of Cortical Development/diagnostic imaging , Autopsy , Brain/anatomy & histology , Brain/diagnostic imaging , Cerebral Cortex/embryology , Congenital Abnormalities/genetics , Congenital Abnormalities/pathology , Female , Fetal Development , Fetus , Gestational Age , Humans , Imaging, Three-Dimensional , Magnetic Resonance Imaging/methods , Malformations of Cortical Development/genetics , Malformations of Cortical Development/pathology , Pregnancy , Pregnancy Trimester, Second , Pregnancy Trimester, Third , Reference Values , Retrospective Studies , Ultrasonography, Doppler, Transcranial/methods , Ultrasonography, Prenatal/methods
9.
J Neonatal Perinatal Med ; 11(2): 191-194, 2018.
Article in English | MEDLINE | ID: mdl-29843264

ABSTRACT

We present here a late preterm infant with extensive brain lesions resulting from vitamin K deficiency. A female infant was born after 35 weeks of gestation by emergent cesarean section because of non-reassuring fetal status. Her mother had severe eating disorder and recurrent vomiting since early pregnancy. She was immediately intubated and ventilated because she was extremely pale, hypotonic, and non-reactive. Cerebral magnetic resonance imaging immediately after birth showed intraparenchymal hemorrhage in the left frontal lobe and cerebellum, marked cerebral edema, and cerebellar hypoplasia. Coagulation studies of the infant showed hepaplastin test <5%, prolonged PT and APTT, and a marked elevation of protein induced by vitamin K absence or antagonist-II. This case highlighted a potential risk of intracranial bleeding due to maternal vitamin K deficiency and difficulty in its prediction before delivery. Vitamin K supplementation to high risk mothers might be indispensable for preventing severe fetal vitamin K deficiency. Even when coagulation studies in mothers is normal, it is imperative to provide vitamin K supplementation for total protection.


Subject(s)
Feeding and Eating Disorders/complications , Intracranial Hemorrhages/etiology , Mothers , Pregnancy Complications, Hematologic/blood , Prenatal Exposure Delayed Effects/blood , Vitamin K Deficiency/complications , Vitamin K/therapeutic use , Adult , Feeding and Eating Disorders/blood , Feeding and Eating Disorders/physiopathology , Female , Humans , Infant, Newborn , Intracranial Hemorrhages/blood , Intracranial Hemorrhages/diagnostic imaging , Maternal Nutritional Physiological Phenomena , Pregnancy , Pregnancy Complications, Hematologic/physiopathology , Prenatal Exposure Delayed Effects/physiopathology , Treatment Outcome , Vitamin K Deficiency/blood , Vomiting/complications
11.
J Fish Biol ; 90(4): 1257-1264, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27873320

ABSTRACT

Adult chum salmon Oncorhynchus keta homing behaviour in a two-choice test tank (Y-maze) was monitored using a passive integrated transponder (PIT)-tag system in response to river-specific dissolved free amino-acid (DFAA) profiles and revealed that the majority of O. keta showed a preference for artificial natal-stream water and tended to stay in this maze arm for a longer period; natal-stream water was chosen over a nearby tributary's water, but not when the O. keta were presented with a non-tributary water. The results demonstrate the ability of O. keta to discriminate artificial stream waters containing natural levels of DFAA.


Subject(s)
Amino Acids/pharmacology , Homing Behavior/drug effects , Oncorhynchus keta/physiology , Rivers/chemistry , Amino Acids/chemistry , Animals
12.
Clin Exp Obstet Gynecol ; 43(3): 341-4, 2016.
Article in English | MEDLINE | ID: mdl-27328487

ABSTRACT

OBJECTIVE: The aim of the present study was to identify predictive data on the short-term outcomes of fetuses with oligohydramnios. MATERIALS AND METHODS: A retrospective study of all pregnancies diagnosed with oligohydramnios was performed. RESULTS: A total of 17 fetuses (seven males, seven females, and three unknown) with oligohydramnios were treated from 2004 to 2011. Oligohydramnios was first diagnosed at a 21.6 ± 4.2 weeks gestation. Terminations of pregnancy before 22 weeks were identified in five cases, and intrauterine fetal deaths occurred in two cases. Ten neonates were born alive, five cases survived over 28 days, and five cases died within 48 hours. Prognostic factors for survival included birth weight (2,457 ± 480 grams in survivors vs. 1973 ± 124 grams in non-survivors; p < 0.05) and the mean amniotic fluid index (AFI) (2.32 ± 1.19 cm in survivors vs. 0.46 ± 0.68 cm in non-survivors;p < 0.05). CONCLUSION: All patients who survived had a mean AFI > 1.0 cm.


Subject(s)
Birth Weight , Fetal Death , Oligohydramnios/mortality , Perinatal Death , Abortion, Induced/statistics & numerical data , Adult , Amniotic Fluid , Congenital Abnormalities , Female , Gestational Age , Humans , Infant, Newborn , Kidney/abnormalities , Kidney Diseases/complications , Kidney Diseases/congenital , Male , Oligohydramnios/etiology , Parturition , Polycystic Kidney, Autosomal Recessive/complications , Pregnancy , Pregnancy Outcome , Prognosis , Retrospective Studies , Severity of Illness Index , Stillbirth , Urogenital Abnormalities/complications , Young Adult
14.
Neuroscience ; 318: 206-18, 2016 Mar 24.
Article in English | MEDLINE | ID: mdl-26779836

ABSTRACT

Prothymosin alpha (ProTα) has robustness roles against brain and retinal ischemia or serum-starvation stress. In the ProTα sequence, the active core 30-amino acid peptide/P30 (a.a.49-78) is necessary for the original neuroprotective actions against ischemia. Moreover, the 9-amino acid peptide sequence/P9 (a.a.52-60) in P30 still shows neuroprotective activity against brain and retinal ischemia, though P9 is less potent than P30. As the previous structure-activity relationship study for ProTα may not be enough, the possibility still exists that any sequence smaller than P9 retains potent neuroprotective activity. When different P9- and P30-related peptides were intravitreally injected 24h after retinal ischemia in mice, the 6-amino acid peptide/P6 (NEVDEE, a.a.51-56) showed potent protective effects against ischemia-induced retinal functional deficits, which are equipotent to the level of P30 peptide in electroretinography (ERG) and histological damage in Hematoxylin and Eosin (HE) staining. Further studies using ERG and HE staining suggested that intravitreal or intravenous (i.v.) injection with modified P6 peptide/P6Q (NEVDQE) potently inhibited retinal ischemia-induced functional and histological damage. In an immunohistochemical analysis, the ischemia-induced loss of retinal ganglion, bipolar, amacrine and photoreceptor cells were inhibited by a systemic administration with P6Q peptide 24h after the ischemic stress. In addition, systemic post-treatment with P6Q peptide significantly inhibited retinal ischemia-induced microglia and astrocyte activation in terms of increased ionized calcium-binding adaptor molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP) intensity, respectively, as well as their morphological changes, increased number and migration. Thus, this study demonstrates the therapeutic significance of modified P6 peptide P6Q (NEVDQE) derived from 6-amino acid peptide (P6) in ProTα against ischemic damage.


Subject(s)
Ischemia/drug therapy , Microglia/drug effects , Neuroprotective Agents/pharmacology , Reperfusion Injury/drug therapy , Retinal Diseases/drug therapy , Animals , Electroretinography/methods , Ischemia/pathology , Male , Mice, Inbred C57BL , Microglia/metabolism , Protein Precursors/pharmacology , Reperfusion Injury/metabolism , Retinal Diseases/physiopathology , Thymosin/analogs & derivatives , Thymosin/pharmacology
15.
Appl Radiat Isot ; 106: 107-10, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26508275

ABSTRACT

Bonner sphere is useful to evaluate the neutron spectrum in detail. We are improving the energy resolution in epi-thermal neutron region of Bonner sphere, using boric acid water solution as a moderator. Its response function peak is narrower than that for polyethylene moderator and the improvement of the resolution is expected. The resolutions between polyethylene moderator and boric acid water solution moderator were compared by simulation calculation. Also the influence in the uncertainty of Bonner sphere configuration to spectrum estimation was simulated.

16.
Diabetes Obes Metab ; 17 Suppl 1: 47-54, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26332968

ABSTRACT

Recent advances in methods for making mammalian organs translucent have made possible whole-body fluorescent imaging with single-cell resolution. Because organ-clearing methods can be used to image the heterogeneous nature of cell populations, they are powerful tools to investigate the hierarchical organization of the cellular circadian clock, and how the clock synchronizes a variety of physiological activities. In particular, methods compatible with genetically encoded fluorescent reporters have the potential to detect circadian activity in different brain regions and the circadian-phase distribution across the whole body. In this review, we summarize the current methods and strategy for making organs translucent (removal of lipids, decolourization of haemoglobin and adjusting the refractive index of the specimen). We then discuss possible applications to circadian biology. For example, the coupling of circadian rhythms among different brain regions, brain activity in sleep-wake cycles and the role of migrating cells such as immune cells and cancer cells in chronopharmacology.


Subject(s)
Brain/physiology , Circadian Clocks/physiology , Circadian Rhythm/physiology , Intravital Microscopy/methods , Neuroimaging/methods , Whole Body Imaging/methods , Animals , Biological Clocks/physiology , Chronotherapy/methods , Histological Techniques/methods , Humans , Mammals/physiology , Microscopy, Fluorescence/methods , Sleep Stages/physiology , Wakefulness/physiology
17.
Appl Radiat Isot ; 104: 25-8, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26133664

ABSTRACT

Bonner sphere is useful to evaluate the neutron spectrum in detail. We are improving the energy resolution in epi-thermal neutron region of Bonner sphere, using boric acid water solution as a moderator. Its response function peak is narrower than that for polyethylene moderator and the improvement of the resolution is expected. The resolutions between polyethylene moderator and boric acid water solution moderator were compared by simulation calculation. Also the influence in the uncertainty of Bonner sphere configuration to spectrum estimation was simulated.


Subject(s)
Boric Acids/chemistry , Boric Acids/radiation effects , Boron Neutron Capture Therapy/instrumentation , Models, Chemical , Neutrons , Radiometry/instrumentation , Absorption, Radiation , Computer Simulation , Computer-Aided Design , Equipment Design , Equipment Failure Analysis , Radiation Dosage , Reproducibility of Results , Sensitivity and Specificity , Solutions , Water/chemistry
18.
Pharmazie ; 70(5): 296-9, 2015 May.
Article in English | MEDLINE | ID: mdl-26062296

ABSTRACT

Actinidin (ATD) is a cysteine protease found in kiwifruit. It is used to tenderize meat and to enhance the digestion of proteins in the small intestine. However, ATD is unstable during freeze-drying, which alters its bioactivity. It is well known that sugars have the ability to protect proteins from the stress of freeze-drying. In this study, we investigated the protective effect of various saccharides on the stability of ATD during freeze-drying. The ATD activities of the samples containing γ-cyclodextrin (CyD) showed only a small decrease, and compared with trehalose and sucrose, γ-CyD was a more effective stabilizer for ATD. Secondary structural changes in freeze-dried ATD were observed by circular dichroism spectroscopy and compared with the changes in stabilized samples. There was a close relationship between the α-helix content and the stabilization. The sugars stabilized the protein by suppressing the changes in the α-helix. Fourier transform infrared spectroscopy measurement showed that the amide I band of ATD with γ-CyD was shifted to a lower wavenumber compared with other sugars. Therefore, stronger hydrogen bonds may be formed between ATD and γ-CyD than between ATD and other sugars. The suppression of changes in the protein secondary structure accompanying the formation of hydrogen bonding between the protein and the sugar also contributed to the protective effect of the sugars.


Subject(s)
Cysteine Endopeptidases/chemistry , Cysteine Proteinase Inhibitors/chemistry , Freeze Drying/methods , gamma-Cyclodextrins/chemistry , Actinidia , Carbohydrates/analysis , Circular Dichroism , Fruit/chemistry , Protein Structure, Secondary , Proteins/chemistry , Spectroscopy, Fourier Transform Infrared
19.
Transfus Med ; 25(1): 42-6, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25752582

ABSTRACT

OBJECTIVE: To prevent neonatal alloimmune thrombocytopenia due to anti-group A antibody perinatal management was performed. BACKGROUND: We previously reported a case of severe intracranial haemorrhage associated with neonatal alloimmune thrombocytopenia due to anti-group A isoantibody. MATERIAL/METHODS: A 40-year-old Japanese woman, gravida 4 para 1, was pregnant with her second baby. The previous sibling developed severe thrombocytopenia and died 10 days after birth due to intracranial haemorrhage. He was diagnosed with neonatal alloimmune thrombocytopenia; the causative antibody was found to be the anti-group A antibody. Prednisone was started at 7 weeks' gestational age. Intravenous immunoglobulin 1 g kg(-1) week(-1) was started at 29 weeks' gestational age and continued to delivery. Serological studies and genotyping were performed. RESULTS: The second boy was delivered at 33 weeks' gestational age by caesarean section. He was discharged without intracranial haemorrhage or thrombocytopenia. The anti-group A antibody titre in the maternal serum was 2048-4096 (normal range: 4-64). The anti-group A antibody titre in the newborn's serum was 4. Cross-matching between the maternal serum and the paternal platelets was positive. CONCLUSION: Owing to the history of neonatal alloimmune thrombocytopenia causing intracranial haemorrhage and death of the previous sibling, strict follow-up of the subsequent pregnancy was conducted.


Subject(s)
ABO Blood-Group System/blood , Fetomaternal Transfusion/therapy , Isoantibodies/blood , Perinatal Care/methods , Thrombocytopenia, Neonatal Alloimmune/therapy , Female , Fetomaternal Transfusion/blood , Humans , Infant, Newborn , Male , Pregnancy , Thrombocytopenia, Neonatal Alloimmune/blood
20.
J Laryngol Otol ; 129(1): 11-5, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25482388

ABSTRACT

OBJECTIVE: Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging has been used to detect alterations in the composition of inner-ear fluid. This study investigated the association between hearing level and the signal intensity of pre- and post-contrast three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging in patients with sudden-onset sensorineural hearing loss. METHOD: Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging was performed in 18 patients with sudden-onset sensorineural hearing loss: 12 patients with mild-to-moderate sensorineural hearing loss (baseline hearing levels of 60 dB or less) and 6 patients with severe-to-profound sensorineural hearing loss (baseline hearing levels of more than 60 dB). RESULTS: High-intensity signals in the inner ear were observed in two of the six patients (33 per cent) with severe-to-profound sensorineural hearing loss, but not in those with mild-to-moderate sensorineural hearing loss (mid-p test, p = 0.049). These signals were observed on magnetic resonance imaging scans 6 or 18 days after sensorineural hearing loss onset. CONCLUSION: The results indicate that three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging is not a useful tool for detecting inner-ear abnormalities in patients with mild sensorineural hearing loss.


Subject(s)
Auditory Threshold/physiology , Ear, Inner/physiopathology , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sudden/diagnosis , Imaging, Three-Dimensional/methods , Magnetic Resonance Imaging/methods , Adult , Aged , Aged, 80 and over , Audiometry , Cochlea/physiopathology , Contrast Media , Female , Hearing Loss, Sensorineural/physiopathology , Hearing Loss, Sudden/physiopathology , Humans , Labyrinthine Fluids , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...